Impact of obesity on the risk of immune-related adverse events (irAEs) among patients receiving immune-checkpoint inhibitors (ICI) treatment: A retrospective cohort study

被引:0
|
作者
Elsaid, Mohamed I.
Paskett, Electra D.
Shendre, Aditi
Manne, Ashish
Li, Lang
机构
[1] Ohio State Univ, Coll Med, Columbus, OH USA
[2] Ohio State Univ, Comprehens Canc Ctr, Columbus, OH USA
[3] Ohio State Univ, Dept Biomed Informat, Columbus, OH USA
[4] Ohio State Univ, Dept Biomed Informat, Coll Med, Columbus, OH USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2660
引用
收藏
页数:1
相关论文
共 50 条
  • [1] Immune-related adverse events (IrAEs) in patients receiving immune checkpoint inhibitors
    Ferrarini, Alessia
    Benfaremo, Devis
    Rossetti, Giulia
    Morgese, Francesca
    Pomponio, Giovanni
    Berardi, Rossana
    Gabrielli, Armando
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2020, 18
  • [2] Association of efficacy and immune-related adverse events (irAEs) in patients with NSCLC receiving immune-checkpoint inhibitors (ICIs)
    Riudavets Melia, M.
    Gabriela Sullivan, I.
    Barba Joaquin, A.
    Anguera Palacios, G.
    del Carpio, L. P.
    Molto Valiente, C.
    Camacho Arellano, S. D.
    Moron Asensio, S.
    Gomila Pons, P.
    Andres Granyo, M.
    Castillo Villegas, D.
    Facundo Molas, C.
    Garcia Planella, E.
    Gonzalez Blanco, C.
    Barnadas Molins, A.
    Gich Saladich, I.
    Majem Tarruella, M.
    [J]. ANNALS OF ONCOLOGY, 2018, 29 : 509 - 509
  • [3] Customized autoantibodies (autoAbs) profiling to predict and monitor immune-related adverse events (irAEs) in patients receiving immune checkpoint inhibitors (ICI)
    Genta, Sofia
    Keshavarzi, Sareh
    Yee, Noelle
    Heirali, Alya
    Hansen, Aaron Richard
    Siu, Lillian L.
    Saibil, Samuel
    Stayner, Lee-Anne
    Yanekina, Maryia
    Sauder, Maxwell
    Salawu, Abdulazeez
    Spiliopoulou, Pavlina
    Vornicova, Olga
    Vilbert, Maysa Tamara Silveira
    Butler, Marcus O.
    Bedard, Philippe L.
    Razak, Albiruni Ryan Abdul
    Coburn, Bryan
    Chruscinski, Andrzej
    Spreafico, Anna
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)
  • [4] A Retrospective Cohort Study of Multiple Immune-Related Adverse Events and Clinical Outcomes Among Patients With Cancer Receiving Immune Checkpoint Inhibitors
    Hata, Hiroki
    Matsumura, Chikako
    Chisaki, Yugo
    Nishioka, Kae
    Tokuda, Misaki
    Miyagi, Kazuyo
    Suizu, Tomoki
    Yano, Yoshitaka
    [J]. CANCER CONTROL, 2022, 29
  • [5] Impact of patient education on immune-related adverse events (irAEs) during immune checkpoint inhibitor (ICI)
    Berger, V. A.
    Jube, C.
    Forestier, A.
    Mitonneau, C.
    Humeau, H.
    Limouzin, S.
    Tiercin, M.
    Morliere, L.
    Geoffrois, L.
    Cabart, M.
    Bertholet, M.
    Llambrich-Molines, C.
    Breysse, S.
    Laghouati, S.
    Beaumont, N.
    [J]. ANNALS OF ONCOLOGY, 2022, 33 (07) : S1285 - S1285
  • [6] Rheumatic immune adverse events related to immune checkpoint inhibitors-(IrAEs related to ICI)
    Tingry, Thomas
    Massy, Emmanuel
    Piperno, Muriel
    Auroux, Maxime
    Kostine, Marie
    Maillet, Denis
    Amini-Adle, Mona
    Fabien, Nicole
    Estublier, Charline
    Goncalves, David
    Girard, Nicolas
    Confavreux, Cyrille B.
    [J]. BULLETIN DU CANCER, 2021, 108 (06) : 643 - 653
  • [7] Comparative analysis of immune-related adverse events among patients with melanoma on immune checkpoint inhibitors: a retrospective cohort study
    Pan, Catherina X.
    Kim, Daniel Y.
    Lau, Charles B.
    Lau, William C.
    Rowley, Rachael
    Kanwar, Ruhi
    Leboeuf, Nicole R.
    Nambudiri, Vinod E.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2023, 189 (05) : 637 - 640
  • [8] Comparative analysis of immune-related adverse events among patients with melanoma on immune checkpoint inhibitors: a retrospective cohort study
    Pan, Catherina X.
    Kim, Daniel Y.
    Lau, Charles B.
    Lau, William C.
    Rowley, Rachael
    Kanwar, Ruhi
    Leboeuf, Nicole R.
    Nambudiri, Vinod E.
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2023,
  • [9] Predictors of endocrine immune-related adverse events (irAEs) in patients treated with immune checkpoint inhibitors (ICI) in routine clinical practice
    Kozhevnikov, Alexander
    Mkrtumyan, Ashot
    Feoktistova, Polina Serrgeevna
    Filonenko, Daria
    Polshina, Natalya
    Volkova, Ekaterina
    Grechukhina, Katerina
    Bykonya, Irina
    Zhukova, Lyudmila
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [10] Real world outcomes of immune-related adverse events (irAEs) among patients receiving immune checkpoint inhibitors (ICIs) in hospital settings
    George, S.
    Zheng, Y.
    Kim, R.
    Yu, T.
    Dreyfus, J.
    Gayle, J. A.
    Wassel, C.
    Phatak, H.
    [J]. ANNALS OF ONCOLOGY, 2019, 30 : 522 - 522